Stockreport

Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results [Yahoo! Finance]

Context Therapeutics Inc.  (CNTX) 
PDF Strengthens board with appointments of Dr. Karen Smith and Dr. Luke Walker Cash and cash equivalents of $84.8 million as of September 30, 2024 “Context executed on [Read more]